Statistics
Publications
2
Citations
250
H-Index
2
Active since
1995
Affiliations
MARK WAGONER is an author at Ligand Pharmaceuticals (United States) specializing in oncology pharmacology, pharmacology, and retinoic acid signaling.
Publications per year
1995–1996
2
2
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
Marco M. Gottardis, Eric D. Bischoff, Michael A. Shirley et al. · PubMed · 1996 · 201 citations
Medicine, Oncology, Pharmacology +17
1–2 of 2